Skip to content

Cancer Biology of Retinoblastoma

Cancer Biology of Retinoblastoma

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01642823
Enrollment
8
Registered
2012-07-17
Start date
2012-07-31
Completion date
2015-12-31
Last updated
2017-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinoblastoma

Keywords

retinoblastoma

Brief summary

Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in retinoblastoma cells but also how cells normally function. Some of these studies will include an evaluation of how cells control the way that genes are expressed, how cells know to become retinal cells, how cells remain retinal cells, how cells lose their identity as retinal cells, what changes make retinoblastoma cells different from normal retinal cells, and what changes make some retinoblastomas worse than others.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 5 Years
Healthy volunteers
No

Inclusion criteria

* Patient must have retinoblastoma * Patient must be receiving biopsy, partial surgical excision of the tumor, complete excision of the tumor, or enucleation of the eye as part of their standard care. * Parental consent

Exclusion criteria

* Diagnosis other than Retinoblastoma * No surgical sampling of tumor is planned as part of standard care * Parental preference to not participate.

Design outcomes

Primary

MeasureTime frameDescription
Change in efficiency of reprogramming in cells with naturally occurring retinoblastoma mutationsAfter appropriate time, e.g., 7, 10, 14 days after reprogrammingComparison of number of reprogramming events (defined by colony formation assay and normalized for number of cell plated) as well as the time to reprogramming.

Countries

Guatemala, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026